Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Emma Iserman"'
Autor:
Olav Versloot, Emma Iserman, Pierre Chelle, Federico Germini, Andrea N. Edginton, Roger E. G. Schutgens, Alfonso Iorio, Kathelijn Fischer, on behalf of the prophylaxis working group of the International Prophylaxis Study Group
Publikováno v:
HemaSphere, Vol 6, Iss 4, p e694 (2022)
Predicting individual effects of switching from standard half-life (SHL) to extended half-life (EHL) FVIII/FIX concentrates is pivotal in clinical care, but large-scale individual data are scarce. The aim of this study was to assess individual change
Externí odkaz:
https://doaj.org/article/f626da3065fe4222aeef113e825b9188
Autor:
Davide Matino, Alfonso Iorio, Arun Keepanasseril, Federico Germini, Alexandre Caillaud, Manuel Carcao, Julia Hews‐Girard, Emma Iserman, Paula James, Adrienne Lee, Chai W. Phua, Haowei (Linda) Sun, Jerome Teitel, Man‐Chiu Poon
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Background The Canadian Bleeding Disorders Registry (CBDR) captures data from 24 hemophilia treatment centers and patients directly. Nonacog beta pegol (N9‐GP) was approved in Canada in 2018. Objectives To assess treatment outcomes followi
Externí odkaz:
https://doaj.org/article/a3a817323130473fb1d767296c6d585b
Autor:
Man-Chiu Poon, Adrienne Lee, Federico Germini, Arun Keepanasseril, Quazi Ibrahim, Francis Nissen, Katya Moreno, Michelle Santos, Emma Iserman, Davide Matino, Alfonso Iorio
Publikováno v:
Blood. 140:8465-8467
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7150e45fa46dff68579ba16540a772a
https://doi.org/10.1182/blood-2022-157531
https://doi.org/10.1182/blood-2022-157531
Autor:
Alfonso Iorio, Emma Iserman, Roger E. G. Schutgens, Andrea N. Edginton, Olav Versloot, Pierre Chelle, Federico Germini, Pharmacokinetic, Krista Fischer
Publikováno v:
Journal of Thrombosis and Haemostasis
Background Real-life data on pharmacokinetics of FVIII/IX concentrates, especially extended half-life (EHL), concentrates in large cohorts of persons with hemophilia are currently lacking. Objectives This cross-sectional study aimed to establish refe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4611bb68aa44b71fb8fffaeba5ee040
http://europepmc.org/articles/PMC8361743
http://europepmc.org/articles/PMC8361743
Autor:
Alfonso Iorio, Sylvain Grenier, David Page, Arun Keepanasseril, Emma Iserman, Jean-Eric Tarride, Davide Matino, Jayson Stoffman, Jerome Teitel, Lorraine Boyle
Publikováno v:
Canadian Journal of Health Technologies. 2
The Canadian Bleeding Disorders Registry (CBDR) has become the national registry for comprehensive care and research in hemophilia in Canada with patient, clinical, and research module connectivity. The CBDR has served as a robust resource to inform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bc49db4c55e157819e992996008a3ab
https://doi.org/10.51731/cjht.2022.425
https://doi.org/10.51731/cjht.2022.425
Autor:
Alfonso Iorio, Vance MacDonald, Alexandre Caillaud, Maria D. Luckevich, Pia Christoffersen, Davide Matino, Arun Keepanasseril, Emma Iserman, Federico Germini, Anthony Bentley, Man-Chiu Poon
Publikováno v:
Res Pract Thromb Haemost
BACKGROUND: The Canadian Bleeding Disorders Registry (CBDR) is a source of real-world data for Canadian patients with hemophilia B. Nonacog beta pegol (N9-GP), an extended half-life (EHL) recombinant factor IX (FIX) concentrate, was awarded a Canadia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160b4d8b40feeb7b7431f6bd7a5fdcf2
https://doi.org/10.1016/j.rpth.2023.100106
https://doi.org/10.1016/j.rpth.2023.100106
Autor:
Olav, Versloot, Emma, Iserman, Pierre, Chelle, Federico, Germini, Andrea N, Edginton, Roger E G, Schutgens, Alfonso, Iorio, Kathelijn, Fischer
Publikováno v:
HemaSphere. 6(4)
Predicting individual effects of switching from standard half-life (SHL) to extended half-life (EHL) FVIII/FIX concentrates is pivotal in clinical care, but large-scale individual data are scarce. The aim of this study was to assess individual change
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5e866cab08f4d5d7ecaa5294f9df63
https://pubmed.ncbi.nlm.nih.gov/35356797
https://pubmed.ncbi.nlm.nih.gov/35356797
Publikováno v:
Journal of Clinical Epidemiology. 109:80-89
The objective of this study was to determine reliability and validity of McMaster PLUS measures of scientific merit and clinical importance of articles in medical journals.Analytic survey of peer-reviewed medical journals was carried out. Articles we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865ab8deb666b420aa2b90efce3dceb5
https://doi.org/10.1016/j.jclinepi.2019.01.010
https://doi.org/10.1016/j.jclinepi.2019.01.010
Autor:
Quazi Ibrahim, Fabian Sanabria, Michelle Santos, Man-Chiu Poon, Emma Iserman, Adrienne Lee, Francis Nissen, Federico Germini, Arun Keepanasseril, Davide Matino, Alfonso Iorio
Publikováno v:
Blood. 138:347-347
Background: The Canadian Hemophilia Bleeding Disorders Registry (CBDR) is a clinical database including data from all Canadian Hemophilia Treatment Centers (HTCs) to assist in the management of hemophilia and other bleeding disorders. The CBDR launch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e031f1ff880435bcf8189f7e6b7acf6c
https://doi.org/10.1182/blood-2021-147195
https://doi.org/10.1182/blood-2021-147195
Autor:
Alfonso Iorio, Krista Fischer, Olav Versloot, Tushara Mathew, Federico Germini, Pierre Chelle, Emma Iserman
Publikováno v:
Blood. 136:22-23
Introduction: Extended half-life concentrates were recently introduced and limited data have shown extended terminal half-life (THL). However, real-life data on pharmacokinetics in large cohorts of patients with haemophilia (PWH) and information on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b9ba244e76894dfccfbb8b3df18460a
https://doi.org/10.1182/blood-2020-141801
https://doi.org/10.1182/blood-2020-141801